NOVARTIS AG financial data

Symbol
NVS on NYSE, NVSEF on OTC
Location
Basel, Switzerland
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 31 Jan 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,975,089,248 shares -3.4%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense $2,367,000,000 USD 2.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Goodwill $24,756,000,000 USD 6.1%
Assets $102,246,000,000 USD 2.3%
Liabilities $58,120,000,000 USD 9.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Interest Expense $246,000,000 USD 14%